Fundraising Fox
Naarden · Pre-Seed–Late Stage · 26 people tracked
Also known as BIOGENERATION III SERVICES B.V.
Find your way into BioGeneration Ventures
Sign up to see every warm intro you have to BioGeneration Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioGeneration Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Seed-focused, investing pre-seed through growth, they leverage Forbion integration for privileged later-stage networks and serve as registered manager bridging academic spin-outs via a DCVA/RegMed pre-seed program.
Source: firm website, verified Sep 27, 2026.
Team · 26 people
from the firm's website & curated & public directories
Founder mafia
5 people who came through BioGeneration Ventures went on to found or lead other companies.
What they invest in
from 40 of 61 portfolio companiesBiotech ×31Healthtech ×23Medical Devices ×18Deep Tech ×14AI & Machine Learning ×8Digital Health ×6SaaS ×5Enterprise Software ×4
HQs:Netherlands×11United States×8Germany×3Belgium×1Switzerland×1India×1
Who they back
founder profiles across 10 portfolio companiesFounding team size:solo founder×63 founders×34+ founders×1
What their founders studiedfrom 11 founders with field-of-study data
Life Sciences ×4Chemistry ×3Medicine ×2
Where their founders worked beforefrom 12 founders with career history
Kiadis Pharma ×2Leiden University Medical Center ×2UMC Utrecht ×2
Investments · 61 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 32023 · 42022 · 62021 · 32020 · 32019 · 12018 · 12017 · 42016 · 12013 · 22007 · 130 dated
Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach.
BiotechDeep TechHealthtech
Tjeerd Barf(Co-founder & CEO)inArwin Ridder(Co-founder & COO)inAd IJzerman(Co-founder & SAB Chair)inJason(Chief Scientific Officer)in
Co-investorsThuja CapitalSeroba Life SciencesBGV
Avidicure develops "Actibody", a triple-agonistic antibody platform built on a human IgG scaffold designed to activate the innate and adaptive immune system for treating oncology and autoimmune diseases.
AI & Machine LearningBiotech
Robert Friesen(Founder)in
Co-investorsEQT Life SciencesBOMCurie CapitalKurma PartnersV-Bio Ventures
Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions.
BiotechDeep TechHealthtechMedical DevicesLeiden, NL
Hans Aerts(Professor)Hermen Overkleeft(Professor)Stan van Boeckel(Professor)
Co-investorsBioMedPartnersForbionJeito CapitalPictet GroupAsahi Kasei Corporate Venture CapitalSeroba Life Sciences
Citryll is a clinical-stage biotech developing CIT-013, an antibody therapy that targets extracellular traps by selectively binding citrullinated histones to both inhibit new trap formation and clear existing ones.
BiotechHealthtechMedical DevicesOss, NL
Renato Chirivi(Co-founder (former CSO))in
BoardPaul Peter Tak(Chair of the Board)
Co-investorsPureos BioventuresSeventure PartnersForbionJohnson & Johnson Innovation – JJDCBOMCurie Capital+1 more
Cristal Therapeutics develops therapeutics in the life sciences sector.
BiotechDeep TechDigital HealthMedical DevicesUtrecht, NL
Dr. Cristianne Rijcken(Chief Scientific Officer and Founder)Dr. Joost Holthuis(Co-founder and former CEO)
Co-investorsChemelot VenturesThuja CapitalBOMDroia VenturesBrightlands Venture Partners
i2020 Accelerator (T123 LLC) is a drug discovery accelerator that de-risks early-stage science and advances drug discovery platforms toward lead and clinical candidate stage within roughly two years, working across therapeutic areas such as oncology, immunology, and infectious diseases.
BiotechDeep TechHealthtechSan Diego, US
Co-investorsTorrey Pines InvestmentOrbiMedBGV
RhyGaze develops gene therapies using optogenetic proteins to restore sight in patients with vision loss caused by retinal photoreceptor dysfunction.
BiotechDigital HealthMedical DevicesBasel, CH
Botond Roska(Researcher (M.D., Ph.D.))Bence György(IOB Assistant Professor & Head of Clinical Translation)inKatherine High(CEO)in
Co-investorsARCH Venture PartnersNovartis Venture FundF-Prime CapitalGV (Google Ventures)
VarmX develops VMX-C001, a therapeutic medicine for treating severe bleeding in patients on Factor Xa anticoagulants and for emergency surgery settings.
BiotechHealthtechMedical Devices
Pieter Reitsma(Founder)inJohn Glasspool(Chief Executive Officer)in
Co-investorsInkefSound BioventuresYsios CapitalEICEQT Life SciencesUNIIQ+2 more
Seattle, US
Meininger David(Executive Officer, Director, Promoter)
BoardRoger Ulrich(Director)Daniel O'Connell(Director)
Board seatEdward van Wezel· per SEC Form D · $17.3M raise · filed Apr 2021
Develops novel therapeutics in oncology and autoimmune diseases.
Co-investorsAvoro Capital AdvisorsBOMFrazier Life Sciences
AiDASH uses satellite imagery and AI to help industries become more resilient, efficient, and sustainable.
AI & Machine LearningCleantechClimate TechEnergySaaSSanta Clara, US
Abhishek Vinod Singh(Chief Executive Officer)in
Co-investorsG2 Venture PartnersNational Grid PartnersSE VenturesThe Lightsmith GroupUnanimous CapitalBenhamou Global Ventures
The company develops therapies for people with severe autoimmune diseases.
BiotechHealthtechMedical Devices
Co-investorsAvoro Capital AdvisorsHBM Healthcare InvestmentsMPM BioImpactPMVSeventure PartnersAescap Life Sciences+2 more
Brandaris Therapeutics is a translational-stage biotech developing first-in-class and best-in-class small-molecule therapies for neuropsychiatric disorders such as depression and anxiety, using a differentiated approach to receptor pharmacology.
BiotechDeep TechMental HealthLeiden, NL
Carboledger provides compliance automation and AI-powered data validation for sustainability reporting across supply chains, helping companies meet evolving regulations like ISCC PLUS, REDCert, RED III, and CORSIA.
Climate TechEnterprise SoftwareSaaS
Nikha Garg(Founder)in
Co-investorsArka Venture LabsAvaana Capital
CatalYm develops immunotherapies for solid tumors by neutralizing GDF-15, a factor cancer cells use to suppress immune responses and resist treatment.
BiotechDeep TechHealthtechMunich, DE
Jörg Wischhusen(Scientific Co-founder)Scott Clarke(Chief Executive Officer)inPeter Garcia(Chief Financial Officer)Sujata Rao(Chief Medical Officer)inStefan Ries(Chief Scientific Officer and Head of Munich Site)inAndrea Goddard(Chief Technical Officer)in
Co-investorsJeito CapitalBioqube VenturesForbionBayern KapitalCanaan Partnerscoparion+2 more
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.
BiotechDigital HealthHealthtechMedical DevicesMunich, DE
Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in
Co-investorsCambridge Innovation CapitalGimvHadean VenturesSeroba Life SciencesBGVForbion+2 more
VIB is a non-profit research institute focused on strategic basic research in life sciences, operating in partnership with five Flemish universities.
BiotechDeep TechMedical DevicesGhent, BE
Jan Steyaert(Founder (Scientific))inCedric Ververken(CEO)in
Co-investorsCapricorn Venture PartnersFund+PMVQuest for GrowthV-Bio Ventures
Epsilogen develops antibody therapeutics based on the IgE, IgA, and IgG immunoglobulin isotypes for the treatment of cancer, matching each isotype to specific tumor types and combining isotypes into single antibody molecules.
BiotechHealthtech
Tim Wilson(Chief Executive Officer)Kevin FitzGerald(Chief Scientific Officer)inCristina Oliva(Chief Medical Officer)inNick Robbins-Cherry(Chief Financial Officer)inElizabeth Hardaker(Chief Translational Science Officer)
Co-investors3B Future Health FundAlbionVCEpidarex CapitalGlobal BioAccess FundNovartis Venture FundUCL Technology Fund
Essenvia offers a regulatory information management platform for medical device regulatory affairs teams, automating submissions (including FDA eSTAR), centralizing registrations, and providing AI-driven regulatory intelligence and lifecycle tracking.
AI & Machine LearningMedical DevicesSaaSWoodland Hills, US
Basant Sahoo(Co-founder & CTO)inSoumya Mahapatra(Co-founder & CEO)in
Co-investorsArka Venture LabsCore91.vcExpert DOJORebright PartnersBenhamou Global VenturesWavemaker Three-Sixty Health
Fibrocor Therapeutics is a drug developer building a pipeline of first-in-class therapeutics that target fibroblast activation to treat fibrotic diseases, with an initial focus on the genetic kidney diseases Alport Syndrome and Autosomal Dominant Polycystic Kidney Disease (ADPKD).
BiotechDeep TechHealthtech
FundaMental Pharma is a preclinical biopharmaceutical company developing dual-acting NMDAR modulators for treatment-resistant depression.
BiotechDigital HealthHeidelberg, DE
Co-investorscoparion
Genase Therapeutics is a biotech company developing cancer therapies that target metabolic vulnerabilities in oncogene-addicted cancers.
BiotechHealthtech
The National Kidney Foundation works to eliminate preventable kidney disease, accelerate innovation in patient care, and address structural inequities in kidney treatment and transplantation services.
HealthtechImpact & Social Good
Co-investorsYsios CapitalEpidarex CapitalRoche Venture FundScottish National Investment BankSofinnova Partners
Kivu Bioscience develops antibody-drug conjugate (ADC) therapeutics in clinical development, advancing a pipeline of cancer treatments through strategic partnerships and collaborations.
BiotechDeep TechHealthtechMedical Devices
Mohit Trikha(CEO)inSophia Randolph(Chief Medical Officer)in
Co-investorsBOMGimvHealthCapM VenturesRed Tree VentureNovo Holdings
Lincode builds LIVIS, an AI-based visual inspection system for manufacturing quality control that lets factory teams train and deploy computer vision models for surface defect detection, assembly verification, and anomaly detection through a no-code interface.
Advanced ManufacturingAI & Machine LearningRobotics
Rajesh Iyengar(CEO)in
Co-investorsAlumni VenturesArka Venture LabsAugment VenturesBasecamp FundExpert DOJOGeek Ventures+4 more
Mellon Medical manufactures a surgical instrument for abdominal wall closure featuring a double-pointed needle, ergonomic jaws, and atraumatic needle-suture combination.
HealthtechMedical DevicesRotterdam, NL
Co-investorsBOMThuja Capital
Mironid is a drug development company building a pipeline of therapies targeting cAMP-degrading phosphodiesterase enzymes to treat Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases.
BiotechMedical Devices
Adele Rowley(Chief Scientific Officer)in
Co-investorsEpidarex CapitalRoche Venture FundSofinnova PartnersScottish National Investment Bank
NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions.
BiotechHealthtechMedical Devices
Co-investorsBain Capital Life SciencesEQT Life SciencesFrazier Life SciencesForbion
NorthSea Therapeutics is a clinical-stage biopharmaceutical company developing oral fatty acid-derived therapies for liver and metabolic diseases, including intestinal failure-associated liver disease (IFALD), severe hypertriglyceridemia, and MASH.
BiotechDigital HealthHealthtech
Co-investorsNew Science VenturesvenBio PartnersYsios CapitalBGVNovo HoldingsSofinnova Ventures+1 more
Phosphoenix is developing a neuroprosthetic system that restores functional vision in people with profound blindness by directly stimulating the brain's visual pathway, targeting the lateral geniculate nucleus.
BiotechDeep TechMedical Devices
Pipeshift provides managed inference infrastructure for deploying and scaling AI models with low latency and high reliability.
AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareSan Francisco, US
Arko C(CEO)inEnrique Ferrao(CTO)inPranav Reddy(CIO)inArko Chattopadhyay(Founder)
Co-investorsArka Venture LabsGood News VenturesMyAsiaVCSenseAI VenturesStrategxy Ventures LLCY Combinator+4 more
River Biomedics develops human cardiac in vitro models used for drug target and compound validation, building a pipeline of cardiac therapies.
BiotechHealthtechMedical Devices
Robert Passier(Founder)in
Co-investorsKIKK CapitalBGVOost NL
Scenic Biotech develops modifier therapy, a genetic medicine approach that targets secondary functions in the genome to neutralize the impact of disease-causing mutations.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtech
Co-investorsBioMedPartnersEIR VenturesInkefOxford Science Enterprises
Soteria Biotherapeutics develops protein-based biotherapeutics and small molecules using its LITE Switch technology platform for drug discovery and development across oncology, immune-oncology, and inflammatory disease indications.
BiotechDeep TechHealthtechMedical DevicesWellness & FitnessSan Francisco, US
Jim Wells(Co-founder, Scientific Advisory Board Chair)Kristine M Ball(Executive Officer, Director)inZachary Hill(Executive Officer, Director)in
BoardNisha Marathe(Director)David Allison(Director)inKeno Gutierrez(Director)in
Co-investors5AM VenturesNovartis Venture FundRoche Venture FundVersant VenturesWestlake Village BioPartners
STANT b.v. develops small-molecule STING pathway antagonists with a differentiated mechanism of action, targeting autoimmune, inflammatory, cardiovascular, metabolic and neurodegenerative diseases such as systemic lupus erythematosus, ALS, Parkinson's and chronic kidney disease.
BiotechDeep TechHealthtechOss, NL
Søren R. PaludanSonia Assil
Synaffix develops antibody-drug conjugate (ADC) technology, providing linker-payload platforms that attach small-molecule, peptide, and protein-based payloads to antibodies for use in targeted cancer therapies.
BiotechDeep TechHealthtech
Co-investorsBOMM Ventures
TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht.
BiotechMedical DevicesUtrecht, NL
Coen Maas(Co-founder)inSteven de Maat(Chief Scientific Officer)inMarc van Moorsel(Director of Operations)inKristof Vercruysse(Chief Executive Officer)inRob Dekker(Vice President CMC)inFilip Van den Wyngaert(Vice President Asset Management)in
Co-investorsAndera PartnersCurie CapitalFund+Hadean VenturesInkefRotrip+1 more
Tessellate Bio is a biotech company researching synthetic lethal interactions beyond Homologous Recombination Deficiency (HRD) to build a pipeline of first-in-class precision medicines.
BiotechHealthtech
Tigatx develops engineered IgA antibodies designed to engage neutrophils as a cancer treatment approach.
Biotech
Co-investorsCivilization Ventures Management, Llc
Totango offers a customer success platform for businesses to manage customer relationships and drive revenue retention and growth, including AI-powered features like account summaries and a customer intelligence engine.
AI & Machine LearningEnterprise SoftwareSaaSSales TechSan Mateo, US
Guy Nirpaz(Founder)inTomer Manor(VP Finance)inKeith Frankel(CEO)inSherman Chu(Director)inTomas Carlos Tovar(Director)Nechemia Jacob Peres(Director)
Co-investorsGreat Hill PartnersBenhamou Global VenturesCanvas VenturesGarage CapitalBGVGemini Israel Ventures+1 more
Trainn is a learning management system (LMS) platform that combines video creation, guide authoring, and course delivery in a single interface designed for enterprises and startups.
AI & Machine LearningEdTechEnterprise SoftwareMarketing TechSaaSChennai, IN
VivekSumana
Co-investorsArka Venture LabsSpeciale Invest
XS Innovations develops medical devices for vascular access in hemodialysis patients.
BiotechHealthtechMedical Devices
Toon Stilma(Co-founder & CEO)Joris Rotmans(Co-founder & CSO (Nephrologist))Koen van der Bogt(Co-founder & CMO (Vascular and transplant surgeon))Ruairi Duffy(CTO)
Co-investorsUNIIQ
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BioCerosBrenigDezima PharmaDunadDunad TherapeuticsFundaMental PharmaLanthioNovioGendixNoviogendix HoldingPhloxProgentix OrthobiologyRougeTxStack IdentitySTANTStaten BiotechnologySurgVisionTanai TherapeuticsVectory
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companies
Mironid · eu-startups.com · Aug 7, 2026
Avidicure · avidicure.com · Jun 27, 2025
Azafaros · biospace.com · May 13, 2025
Fund performance · per public LP disclosures
as of Jun 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Biogeneration Capital Fund V Cooperatief U.A.LPs: California Public Employees' Retirement System | 2023 | — | — | 1.20x | 0.00x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- How many investments has BioGeneration Ventures made?
- BioGeneration Ventures has 61 tracked investments, including 2 dated in the last 24 months.
- What stage does BioGeneration Ventures invest at?
- BioGeneration Ventures invests at the Pre-Seed, Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does BioGeneration Ventures focus on?
- BioGeneration Ventures focuses on Biotech, Healthtech, Medical Devices.
- Where is BioGeneration Ventures located?
- BioGeneration Ventures is headquartered in Naarden, NL.
- Does BioGeneration Ventures lead rounds?
- Yes, BioGeneration Ventures leads investment rounds.
- Who does BioGeneration Ventures co-invest with?
- BioGeneration Ventures most often shares deals with BOM, Epidarex Capital, Inkef, among 53 tracked co-investors.
- What size deals does BioGeneration Ventures back?
- Across 12 deals with disclosed amounts, BioGeneration Ventures has joined rounds of $1M – $92M (median $15.5M).
Media · Podcasts & interviews
featuring the team#153 Edward van Wezel, BioGeneration Ventures
The European VC · Edward van Wezel
EUVC #45 Daniela Couto, Biogeneration Ventures
EUVC · Daniela Couto
Images
Co-investors · 36
Forbion is a global venture capital firm focused on advancing biotech innovations and other sustainable solutions aimed at improving human and planetary health.
The Novartis Venture Fund invests in innovative life science companies, primarily in biotechnology and biopharmaceuticals, at various stages of development across North America and Europe.
Inkef Capital is an early-stage, hands-on investor that partners with founders to build companies with a long-term strategic vision.
Roche Venture Fund is a corporate venture arm that invests in early-stage biotech and diagnostics companies across more than 10 countries, with a portfolio exceeding 30 portfolio companies. The fund is headquartered in Basel, Switzerland.
Benhamou Global Ventures (BGV) is a cross-border venture capital platform based in Silicon Valley that invests from seed stage through IPO, providing both financial and human capital to entrepreneurs.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Seventure Partners is a European venture capital firm backing innovative companies across life sciences and digital technologies, with additional focus areas in sport & performance and the blue economy.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Canvas Prime (formerly Canvas Ventures) is an early-stage venture firm that leads Series A and B investments, focusing on AI applied to digital health and fintech.
G2 Venture Partners is a venture capital firm that invests in technology companies at their inflection points to help transform traditional industries toward sustainability.
National Grid Partners is the venture capital unit of National Grid plc, a major investor-owned energy utility company. The firm invests in innovative energy-related technologies and business models.
Johnson & Johnson Innovation is the innovation arm of Johnson & Johnson, working to advance life science innovation through early partnerships, incubation via JLABS, venture investing through JJDC, and late-stage partnerships to address global health challenges.
▶24 more co-investors
Andera PartnersWestlake Village BioPartnersAvaana CapitalSpeciale InvestBayern KapitalSenseAI VenturesWavemaker Three-Sixty HealthAndreessen HorowitzPlug and Play VenturesPartech VenturesEmergence Capital PartnersRidge VenturesStandard CapitalPelion Venture PartnersWildcat Venture PartnersDnx VenturesFusionWestWave CapitalToyota VenturesInventus Capital PartnersMorpheus VenturesTakwin VenturesFirst Rays Venture PartnersD.E. Shaw
Firms observed investing alongside BioGeneration Ventures, from public investor directories. Shared companies are the overlap with BioGeneration Ventures's recorded portfolio.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Forbion is a global venture capital firm focused on advancing biotech innovations and other sustainable solutions aimed at improving human and planetary health.
SMBC Venture Capital is a Japanese venture capital firm and a member of Sumitomo Mitsui Financial Group (SMBC Group), with over 20 years of investing experience. It leverages the group's network of auditors, securities firms, and other investors to support startups.
Mitsui Global Investment is an investment firm that provides capital and hands-on support to entrepreneurs, helping innovative teams scale their businesses onto the global stage.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.